Tapinor 1% Cream 30gm

Uses of Tapinor 1% Cream

• Psoriasis.

How does Tapinor 1% Cream work?

Tapinor 1% Cream works by slowing down the excessive production of skin cells.

Side Effects of Tapinor 1% Cream

• Burning/stinging sensation
• Skin irritation
• Itching
• Itchy rash
• Skin redness
• Dry skin
• Peeling skin
• Dermatitis (skin inflammation)

Quick Suggestions:

• Tapinor 1% Cream should be applied as per the dose and duration suggested by the doctor.
• Before each application, wash the affected area with soap and water and dry well.
• Do not apply to broken, diseased, infected, inflamed, or irritated skin, or to open wounds.
• Avoid getting it in the eyes, mouth, or nose. Rinse with cold water if you accidentally get it in these areas.
• Consult your doctor if your skin condition has not improved after 2-4 weeks of treatment.
• Avoid direct contact with sunlight. Use sunscreen or wear protective clothing while stepping out.

Indication of Tapinor 1% Cream

Tapinor 1% Cream is used to treat a certain skin condition (plaque psoriasis). Tapinarof can help lessen the symptoms of plaque psoriasis (such as red, scaly patches of skin).

Pharmacology

This cream contains Tapinarof as the active ingredient. Tapinarof is an Aryl hydrocarbon Receptor (AhR) agonist. The specific mechanisms by which Tapinarof cream exerts its therapeutic action in psoriasis patients are unknown.

Usage Instructions of Tapinor 1% Cream

• For external use only.
• Use exactly as prescribed by your doctor.
• Ensure the affected area is clean and dry before application.
• Wash hands thoroughly before and after applying the ointment.
• Use regularly for maximum benefit.
• Do not exceed the prescribed amount to avoid increased side effects.
• Consult your doctor if the condition persists beyond four weeks or worsens.

Interaction

Inform your doctor about all the medicines you use, including prescription and non-prescription medicines, and herbal supplements.

Contraindications

Hypersensitive to any of its components.

Pregnancy & Lactation

Pregnancy: The available data on Tapinarof cream use in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. In animal reproduction studies, subcutaneous administration of Tapinarof to pregnant rats and rabbits during the period of organogenesis resulted in no significant adverse effects at doses 268 and 16 times, respectively, the maximum recommended human dose (MRHD). The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of major birth defects, loss, and other adverse outcomes.

Lactation: No data are available regarding the presence of Tapinarof in human milk or the effects of Tapinarof on the breastfed infant or on milk production. Tapinarof was detected in rat offspring following subcutaneous administration to pregnant female rats which suggests that tapinarof was transferred into the milk of lactating rats. When a drug is present in animal milk, it is likely that the drug will be present in human milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Tapinarof cream and any potential adverse effects on the breastfed infant from Tapinarof cream or from the underlying maternal condition.

Precautions & Warnings

• Inform your doctor if you are allergic to Tapinor 1% Cream or any of its components.
• Disclose any history of liver or kidney diseases, hypercalcemia (high calcium levels in the blood), or hypervitaminosis D (excess Vitamin D levels in the blood) to your doctor.
• Use Tapinor 1% Cream only with proper consultation and caution if you are pregnant or breastfeeding.
• Ensure Tapinor 1% Cream does not come into contact with your eyes, nose, or mouth. Rinse thoroughly with water if contact occurs.
• Tapinor 1% Cream is not recommended for children under 12 years of age.
• If you do not notice any improvement in your condition after using Tapinor 1% Creaml for one to two weeks, consult your doctor.

Storage Conditions:

• Keep Tapinor 1% Cream out of reach of children
• Store below 25°C